Neuromuscular Blocking Agents
"Neuromuscular Blocking Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc.
| Descriptor ID |
D009466
|
| MeSH Number(s) |
D27.505.696.663.700.710
|
| Concept/Terms |
Neuromuscular Blocking Agents- Neuromuscular Blocking Agents
- Agents, Neuromuscular Blocking
- Blocking Agents, Neuromuscular
- Neuromuscular Blockers
- Blockers, Neuromuscular
|
Below are MeSH descriptors whose meaning is more general than "Neuromuscular Blocking Agents".
Below are MeSH descriptors whose meaning is more specific than "Neuromuscular Blocking Agents".
This graph shows the total number of publications written about "Neuromuscular Blocking Agents" by people in this website by year, and whether "Neuromuscular Blocking Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neuromuscular Blocking Agents" by people in Profiles.
-
Critical Care Pharmacist Attitudes and Perceptions of Neuromuscular Blocker Infusions in ARDS. Ann Pharmacother. 2023 11; 57(11):1282-1290.
-
Physicians' attitudes and perceptions of neuromuscular blocker infusions in ARDS. J Crit Care. 2022 12; 72:154165.
-
Neuromuscular and Clinical Recovery in Thoracic Surgical Patients Reversed With Neostigmine or Sugammadex. Anesth Analg. 2021 08 01; 133(2):435-444.
-
Anesthetic Management During Electroconvulsive Therapy in Children: A Systematic Review of the Available Literature. Anesth Analg. 2020 01; 130(1):126-140.
-
Intraoperative Use of Nondepolarizing Neuromuscular Blocking Agents During Cardiac Surgery and Postoperative Pulmonary Complications: A Prospective Randomized Trial. J Cardiothorac Vasc Anesth. 2019 Jun; 33(6):1673-1681.
-
Neuromuscular blockers and reversal agents and their impact on anesthesia practice. Best Pract Res Clin Anaesthesiol. 2018 Jun; 32(2):203-211.
-
Perioperative Pharmacologic Considerations in Obesity. Anesthesiol Clin. 2017 Jun; 35(2):247-257.
-
Neuromuscular Blocking Agents and Neuromuscular Dysfunction Acquired in Critical Illness: A Systematic Review and Meta-Analysis. Crit Care Med. 2016 Nov; 44(11):2070-2078.
-
Early Mobilization and Rehabilitation of Patients Who Are Critically Ill. Chest. 2016 09; 150(3):722-31.
-
What Is the Time to Muscle Relaxation After Intramuscular Administration of Neuromuscular Blockers? Ann Emerg Med. 2015 Oct; 66(4):390-3.